VVOS — VIVOS THERAPEUTICS INC COM NEW

Ownership history in Kozak & Associates, Inc.  ·  9 quarters on record

AI Ownership Summary

Kozak & Associates, Inc. reported VIVOS THERAPEUTICS INC COM NEW (VVOS) in 9 quarterly 13F filings from 2023 Q4 through 2025 Q4. The latest visible filing shows VVOS at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this VVOS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Kozak & Associates, Inc.'s position in VIVOS THERAPEUTICS INC COM NEW, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2025 Q4

VVOS was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2025 Q4

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

VVOS stock page Kozak & Associates, Inc. fund profile Kozak & Associates, Inc. full holdings
How Kozak & Associates, Inc. held VVOS — position size vs. price
% of Fund (quarterly)    VVOS price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 9 quarters  ▾
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2025 Q4 UNCHANGED 49 — 0% 0.00% $101 2026-02-14 (Est.) $1.52
2025 Q3 UNCHANGED 49 — 0% 0.00% $117 2025-11-18 $2.47
2025 Q2 UNCHANGED 49 — 0% 0.00% $294 2025-07-10 $6.67
2025 Q1 UNCHANGED 49 — 0% 0.00% $110 2025-04-15 $2.19
2024 Q4 UNCHANGED 49 — 0% 0.00% $214 2025-01-06 $4.24
2024 Q3 UNCHANGED 49 — 0% 0.00% $124 2024-10-17 $2.44
2024 Q2 UNCHANGED 49 — 0% 0.00% $118 2024-07-05 $2.30
2024 Q1 UNCHANGED 49 — 0% 0.00% $111 2024-05-17 $2.29
2023 Q4 INITIATED 49 — — 0.00% $351 2024-01-17 $6.82

🏢 Other funds also holding VVOS

As of 2025 Q4 — sorted by position size

Cutter & CO Brokerage, Inc. 3Y 7Y 0.03% Acorn Wealth Advisors, LLC 3Y 7Y 0.01% DRW Securities, LLC 3Y 7Y 0.01% B. Riley Wealth Advisors, Inc. 3Y 7Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% COMMONWEALTH EQUITY SERVICES, LLC 3Y 7Y 0.0% SIGNATUREFD, LLC 3Y 7Y 0.0% VANGUARD GROUP INC 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% UBS Group AG 3Y 7Y 0.0%

FAQ About Kozak & Associates, Inc. and VVOS

These are the practical questions this page is built to answer before you even open the full history table.

How long has Kozak & Associates, Inc. reported owning VVOS?

Kozak & Associates, Inc. reported VVOS across 9 quarterly 13F filings, from 2023 Q4 through 2025 Q4.

What was the largest reported VVOS position in Kozak & Associates, Inc.'s portfolio?

The largest reported portfolio weight for VVOS was 0.00% in 2023 Q4.

What is the latest reported VVOS position on this page?

The most recent filing on this page is 2025 Q4, when Kozak & Associates, Inc. reported 49 shares, equal to 0.00% of portfolio, with an estimated market value of $101.

What does the chart on this VVOS ownership page compare?

The chart compares Kozak & Associates, Inc.'s quarterly VVOS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to Kozak & Associates, Inc. Holdings